Clinical trialNCT00526799TerminatedPhase 1/PHASE2Interventional

Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer

SponsorDaniela Matei, MDEnrollment30Ovarian Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniela Matei, M.D.
Hoosier Oncology Group, Inc.
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
St. Vincent Hospital Cynecologic Oncology
Indianapolis, Indiana, United States
Arnett Cancer Care
Lafayette, Indiana, United States
Medical Consultants, P.C.
Muncie, Indiana, United States
Schwartz Gynecologic Oncology, Pllc
Brightwaters, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2007
Primary completion: 31 Jan 2010
Completion: 31 Aug 2010
Last update posted: 3 Mar 2016
Registered enrollment: 30
Registry id: NCT00526799

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.